会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • INTRACELLULAR COMPLEXES AS BIOMARKERS
    • 细胞内复合物作为生物标志物
    • WO2004087887A2
    • 2004-10-14
    • PCT/US2004009805
    • 2004-03-30
    • ACLARA BIOSCIENCES INCSINGH SHARATBADAL M YOUSSOUFJIN XUENGUANGSALIMI-MOOSAVI HOSSEIN
    • SINGH SHARATBADAL M YOUSSOUFJIN XUENGUANGSALIMI-MOOSAVI HOSSEIN
    • A61B20060101C07K16/28C12N20060101C12Q3/00G01N33/542G01N33/543G01N33/574C12N
    • G01N33/57492C07K16/2863G01N33/542G01N2333/485G01N2800/52
    • The invention provides a method for determining a disease status of a patient by measuring expression levels of selected intracellular complexes. In one aspect of the invention, the activation status of apoptotic pathways in a patient sample is determined by measuring relative amounts of protein-protein complexes that are characteristic of the apoptotic pathways. In particular, the invention provides a method of determining the activation status of the mitochondrial apoptotic pathway by simultaneously measuring relative amounts of complexes between 14-3-3 proteins and BAD proteins on the one hand and complexes of Bcl-2 proteins and BAD proteins on the other hand. Preferably, methods of the invention are implemented by using sets of binding compounds having releasable molecular tags that are specific for multiple components of one or more complexes formed within apoptotic pathways. After binding molecular tags are released and separated from the assay mixture for analysis.
    • 本发明提供了一种通过测量所选细胞内复合物的表达水平来确定患者的疾病状态的方法。 在本发明的一个方面,通过测量凋亡通路特征的蛋白质 - 蛋白质复合物的相对量来确定患者样品中凋亡途径的活化状态。 特别地,本发明提供了一种通过同时测量14-3-3蛋白和BAD蛋白之间的复合物的相对量以及Bcl-2蛋白和BAD蛋白的复合物的相对量来确定线粒体凋亡途径的激活状态的方法 另一方面。 优选地,本发明的方法通过使用具有可释放分子标签的结合化合物组来实现,所述可释放分子标签对在凋亡途径内形成的一种或多种复合物的多种组分是特异性的。 结合分子标签后,从测定混合物中分离出分子标签进行分析。